Reuters logo
BRIEF-Oncolys BioPharma plans capital alliance with bio firm in vaccine business
March 29, 2017 / 6:39 AM / 6 months ago

BRIEF-Oncolys BioPharma plans capital alliance with bio firm in vaccine business

March 29 (Reuters) - Oncolys BioPharma Inc :

* Says the company plans to enter into a capital alliance with University of Washington-originated bio firm Precision Virologics Inc which is engaged in R&D of vaccine for emerging infectious disease, in April

* Says co was granted to own right of veto regarding all projects of Precision Virologics in Asia area

* Co will use $500,000 to acquire shares issued by Precision Virologics, and will own about 14 percent stake in it after transaction

* Business expects to initiate since April

Source text in Japanese: goo.gl/TPt2SS

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below